News Releases

February 2020

February 14, 2020 2/14/2020 Investigational Subcutaneous Vedolizumab Achieves Clinical Remission at Week 52 in Patients with Moderately to Severely Active CD

February 5, 2020 2/5/2020 Takeda Demonstrates Ongoing Commitment in Rare Hematology By Continuing to Gather Real-World Evidence and Advance Personalized Treatment

February 4, 2020 2/4/2020 Notice of the Revised Forecast of Consolidated Financials for FY2019 (IFRS)

February 4, 2020 2/4/2020 Takeda Demonstrates Business Momentum, Accelerated Integration Synergies, and Raises FY2019 Guidance Including Positive Reported Operating Profit

January 2020

January 30, 2020 1/30/2020 Takeda Named Global Top Employer for Third Year Running

January 22, 2020 1/22/2020 Takeda Announces Liquidation of Holding Company

January 21, 2020 1/21/2020 Takeda Named Global Top 100 Most Sustainable Corporation for Fifth Year Running

January 14, 2020 1/14/2020 Takeda To Outline Progress on Business Transformation and Priorities at the 38th Annual J.P. Morgan Healthcare Conference

January 8, 2020 1/8/2020 Takeda to Present at the 38th Annual J.P. Morgan Healthcare Conference

・For legacy Shire information, click here